glp-1 small molecule How Receptor Agonists Evolved from Diabetes Treatments to Weight Loss Treatments A Small-Molecule Oral Agonist of

PlexusDx patients interested in exploring personalized, evidence-based weight loss regimens can consult with their clinical team about whether combination approaches align with their metabolic profile, genetic predispositions, and health goals

Same 30-minute waiting period

From prescription injections such as Ozempic and Wegovy to newer products like GLP-1 patches, interest in this gut hormone has grown significantly

These include: Nausea and vomiting (very common, affecting more than 1 in 10 patients) Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite These symptoms often diminish over several weeks as the body adjusts to the medication